Form 8-K - Current report:
SEC Accession No. 0001213900-25-001671
Filing Date
2025-01-07
Accepted
2025-01-07 16:38:23
Documents
14
Period of Report
2024-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227069-8k_pmgchold.htm   iXBRL 8-K 51481
2 ASSET PURCHASE AGREEMENT DATED AS OF DECEMBER 31, 2024 ea022706901ex10-1_pmgchold.htm EX-10.1 451206
  Complete submission text file 0001213900-25-001671.txt   750379

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elab-20241223.xsd EX-101.SCH 3027
4 XBRL LABEL FILE elab-20241223_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE elab-20241223_pre.xml EX-101.PRE 22797
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0227069-8k_pmgchold_htm.xml XML 3963
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25515341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)